Vaccination contre l'hépatite B: vers la fin du tunnel ? = Hepatitis B vaccination: The end of the tunnel?PIROTH, Lionel.Virologie (Montrouge). 2011, Vol 15, Num 4, pp 215-221, issn 1267-8694, 7 p.Article

Particularités de la co-infection VIH et hépatites virales : HEPATITES VIRALES = HIV and viral hepatitis coinfection: specificities : Viral hepatitisPIROTH, Lionel.La Revue du praticien (Paris). 2011, Vol 61, Num 1, pp 65-67, issn 0035-2640, 3 p.Article

Prise en charge des malades coinfectés VIH-VHC et VIH-VHB : Coinfection VHC-VIH = Natural history of factors influencing the severity of chronic HCV infection in HIV-HCV coinfected patientsCACOUB, Patrice; PIROTH, Lionel.Gastroentérologie clinique et biologique. 2007, Vol 31, Num 10, pp 887-894, issn 0399-8320, 8 p.Article

In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumoniaCROISIER, Delphine; MARTHA, Benoit; PIROTH, Lionel et al.International journal of antimicrobial agents (Print). 2008, Vol 32, Num 6, pp 494-498, issn 0924-8579, 5 p.Article

Faut-il instaurer le traitement antirétroviral plus tôt ? = Should we start antiretroviral therapy earlier ?PIROTH, Lionel.La Lettre de l'infectiologue. 2008, Vol 23, Num 5, pp 184-187, issn 0296-9009, 4 p.Article

Co-infections VIH et VHB et foie : Confrontation anatomo-viro-clinique de l'Hôpital Rothschild (Paris) = Coinfection HIV-HBV and the liverPIROTH, Lionel; WENDUM, Dominique; PIALOUX, Gilles et al.Gastroentérologie clinique et biologique. 2001, Vol 25, Num 10, pp 875-877, issn 0399-8320Article

Treatment of chronic hepatitis C in HIV-infected patients : From clinical trials to field practicePIROTH, Lionel; MARTHA, Benoit; MINELLO, Anne et al.Scandinavian journal of infectious diseases. 2008, Vol 40, Num 6-7, pp 561-564, issn 0036-5548, 4 p.Article

Efficacy of humanlike Augmentin SR (2000/125 mg) twice daily treatment on Haemophilus influenzae experimental pneumonia in rabbitsCROISIER, Delphine; BENOIT, Martha; DURAND, David et al.Scandinavian journal of infectious diseases. 2007, Vol 39, Num 2, pp 115-121, issn 0036-5548, 7 p.Article

In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutantsCROISIER, Delphine; ETIENNE, Manuel; PIROTH, Lionel et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 3, pp 640-647, issn 0305-7453, 8 p.Article

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responsesNICOLLIER-JAMOT, Béatrice; OGIER, Agathe; PIROTH, Lionel et al.Vaccine. 2004, Vol 22, Num 9-10, pp 1079-1086, issn 0264-410X, 8 p.Article

Spondylodiscite aiguë à Gemella haemolysans chez une patiente immunocompétente = Acute Gemella haemolysans spondylodiscitis in an immunocompetent patientMARTHA, Benoit; DUONG, Michel; BUISSON, Marielle et al.La Presse médicale (1983). 2003, Vol 32, Num 27, pp 1273-1275, issn 0755-4982, 3 p.Article

Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cellsHEYING, Ruth; VAN DE GEVEL, Joke; QUE, Yok-Ai et al.Thrombosis and haemostasis. 2009, Vol 101, Num 3, pp 495-504, issn 0340-6245, 10 p.Article

Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniaeDESBIOLLES, Norbert; PIROTH, Lionel; LEQUEU, Catherine et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 12, pp 3328-3333, issn 0066-4804Article

Metabolic Syndrome in French HIV-Infected Patients: Prevalence and Predictive Factors After 3 Years of Antiretroviral TherapyBIRON, Antoine; BOBIN-DUBIGEON, Christine; BARD, Jean-Marie et al.AIDS research and human retroviruses. 2012, Vol 28, Num 12, pp 1672-1678, issn 0889-2229, 7 p.Article

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapyPIROTH, Lionel; CARRAT, Fabrice; POL, Stanislas et al.Journal of hepatology. 2008, Vol 49, Num 6, pp 892-898, issn 0168-8278, 7 p.Article

Hepatic steatosis in HIV-HCV coinfected patients : analysis of risk factorsBANI-SADR, Firouzé; CARRAT, Fabrice; BEDOSSA, Pierre et al.AIDS (London). 2006, Vol 20, Num 4, pp 525-531, issn 0269-9370, 7 p.Article

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimenLE MOING, Vincent; CHENE, Geneviève; CARRIERI, Maria P et al.AIDS (London). 2002, Vol 16, Num 1, pp 21-29, issn 0269-9370Article

New model of ventilator-associated pneumonia in immunocompetent rabbitsCHARLES, Pierre-Emmanuel; PIROTH, Lionel; DESBIOLLES, Norbert et al.Critical care medicine. 2002, Vol 30, Num 10, pp 2278-2283, issn 0090-3493, 6 p.Article

Relative impact of ribavirin monitoring and HIV coinfection on sustained virological response in patients with chronic hepatitis CPIEDOUX, Sarah; MONNET, Elisabeth; PIROTH, Lionel et al.Antiviral therapy (London). 2011, Vol 16, Num 8, pp 1317-1326, issn 1359-6535, 10 p.Article

The Fibrinogen-and Fibronectin-Binding Domains of Staphylococcus aureus Fibronectin-Binding Protein A Synergistically Promote Endothelial Invasion and Experimental EndocarditisPIROTH, Lionel; QUE, Yok-Ai; WIDMER, Eleonora et al.Infection and immunity. 2008, Vol 76, Num 8, pp 3824-3831, issn 0019-9567, 8 p.Article

Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapyCROISIER, Delphine; ETIENNE, Manuel; BERGOIN, Emilie et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1699-1707, issn 0066-4804, 9 p.Article

Clinical, immunological and virological evolution in patients with CD4 T-cell count above 500/mm³: Is there a benefit to treat with highly active antiretroviral therapy (HAART)?PIROTH, Lionel; BINQUET, Christine; BUISSON, Marielle et al.European journal of epidemiology. 2004, Vol 19, Num 6, pp 597-604, issn 0393-2990, 8 p.Article

Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1: A Randomized Controlled TrialLAUNAY, Odile; VAN DER VLIET, Diane; CARRAT, Fabrice et al.JAMA, the journal of the American Medical Association. 2011, Vol 305, Num 14, pp 1432-1440, issn 0098-7484, 9 p.Article

Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: Modifications in three consecutive large surveys between 2004 and 2009CACOUB, Patrice; HALFON, Philippe; POL, Stanislas et al.Journal of hepatology. 2010, Vol 53, Num 2, pp 230-237, issn 0168-8278, 8 p.Article

Ocular Syphilis and HIV InfectionBIOTTI, Damien; BIDOT, Samuel; MAHY, Sophie et al.Sexually transmitted diseases. 2010, Vol 37, Num 1, pp 41-43, issn 0148-5717, 3 p.Article